Cargando…
Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice
Background: Patient involvement is often acknowledged as an important aspect of the lifecycle of medicines. Although different typologies exist, patient involvement has been described as the involvement of patients in decision-making regarding medicines. In view of the diversity of stakeholders and...
Autores principales: | Janssens, Rosanne, van Overbeeke, Eline, Verswijvel, Lotte, Meeusen, Lissa, Coenegrachts, Carolien, Pauwels, Kim, Dooms, Marc, Stevens, Hilde, Simoens, Steven, Huys, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193089/ https://www.ncbi.nlm.nih.gov/pubmed/30364285 http://dx.doi.org/10.3389/fmed.2018.00285 |
Ejemplares similares
-
Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives
por: van Overbeeke, Eline, et al.
Publicado: (2020) -
Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey
por: Grine, Lynda, et al.
Publicado: (2020) -
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA
por: Janssens, Rosanne, et al.
Publicado: (2019) -
Off-label use of orphan medicinal products: a Belgian qualitative study
por: Dooms, Marc, et al.
Publicado: (2016) -
Financial based agreements and performance based agreements: the Belgian experience
por: Pauwels, Kim, et al.
Publicado: (2015)